Skip to main content
SpringerLink
Log in

Controverse

Debate

  • Published:
Côlon & Rectum

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. Belot A, Grosclaude P, Bossard N, et al (2008) Cancer incidence and mortality in France over the period 1980–2005. Rev Epidemiol Sante Publique 56:159–75

    Article  CAS  PubMed  Google Scholar 

  2. Verberne CJ, de Bock GH, Pijl ME, et al (2012) Palliative resection of the primary tumour in stage IV rectal cancer. Colorectal Dis 14:314–9

    Article  CAS  PubMed  Google Scholar 

  3. Faron M, Pignon JP, Malka D, et al (2015) Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials. Eur J Cancer 51:166–76

    Article  PubMed  Google Scholar 

  4. Venderbosch S, de Wilt JH, Teerenstra S, et al (2011) Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature. Ann Surg Oncol 18:3252–60

    Article  PubMed  PubMed Central  Google Scholar 

  5. Stillwell AP1, Buettner PG, Ho YH (2010) Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone. World J Surg 34: 797–807

    Article  CAS  PubMed  Google Scholar 

  6. Ishihara S, Hayama T, Yamada H, et al (2014) Prognostic impact of primary tumor resection and lymph node dissection in stage IV colorectal cancer with unresectable metastasis: a propensity score analysis in a multicenter retrospective study. Ann Surg Oncol 21:2949–55

    Article  PubMed  Google Scholar 

  7. Tarantino I, Warschkow R, Worni M, et al (2015) Prognostic relevance of palliative primary tumor removal in 37,793 metastatic colorectal cancer patients: a population-based, propensity score-adjusted trend analysis. Ann Surg 262:112–20

    Article  PubMed  Google Scholar 

  8. Poultsides GA, Servais EL, Saltz LB, et al (2009) Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol 27:3379–84

    Article  PubMed  PubMed Central  Google Scholar 

  9. Kim MS, Chung M, Ahn JB, et al (2014) Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis. J Surg Oncol 110:214–21

    Article  PubMed  Google Scholar 

  10. Ruo L, Gougoutas C, Paty PB, et al (2003) Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg 196:722–8

    Article  PubMed  Google Scholar 

  11. Panis Y, Maggiori L, Caranhac G, et al (2011) Mortality after colorectal cancer surgery: a French survey of more than 84,000 patients. Ann Surg 254:738–43

    Article  PubMed  Google Scholar 

  12. Tekkis PP, Kinsman R, Thompson MR, et al (2004) The Association of Coloproctology of Great Britain and Ireland study of large bowel obstruction caused by colorectal cancer. Ann Surg 240: 76–81

    Article  PubMed  PubMed Central  Google Scholar 

  13. Crane CH, Janjan NA, Abbruzzese JL, et al (2001) Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer. Int J Radiat Oncol Biol Phys 49:107–16

    Article  CAS  PubMed  Google Scholar 

  14. Giantonio BJ, Catalano PJ, Meropol NJ, et al (2007) Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (Folfox4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 25:1539–44

    Article  CAS  PubMed  Google Scholar 

  15. Ghiringhelli F, Bichard D, Limat S, et al (2014) Bevacizumab efficacy in metastatic colorectal cancer is dependent on primary tumor resection. Ann Surg Oncol 21:1632–40

    Article  PubMed  PubMed Central  Google Scholar 

Références

  1. A Venook, D Niedzwiecki, HJ Lenz, et al (2014) CALGB/SWOG 80405: phase III trial of irinotecan/5-fu/leucovorin (Folfiri) or oxaliplatin/5-fu/leucovorin (mFolfox6) with bevacizumab (bv) or cetuximab (cet) for patients (pts) with kras wild-type (wt) untreated metastatic adenocarcinoma of the colon. Ann Oncol 25:ii112–ii3

    Google Scholar 

  2. Loupakis F, Cremolini C, Masi G, et al (2014) Initial therapy with Folfoxiri and bevacizumab for metastatic colorectal cancer. N Engl J Med 371:1609–18

    Article  PubMed  Google Scholar 

  3. de Mestier L, Manceau G, Neuzillet C, et al (2014) Primary tumor resection in colorectal cancer with unresectable synchronous metastases: a review. World J Gastrointest Oncol 6:156–69

    Article  PubMed  PubMed Central  Google Scholar 

  4. Faron M, Pignon JP, Malka D, et al (2015) Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials. Eur J Cancer 51:166–76

    Article  PubMed  Google Scholar 

  5. Stillwell AP1, Buettner PG, Ho YH (2010) Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone. World J Surg 34:797–807

    Article  CAS  PubMed  Google Scholar 

  6. Ahmed S, Shahid RK, Leis A, et al (2013) Should noncurative resection of the primary tumour be performed in patients with stage IV colorectal cancer? A systematic review and meta-analysis. Curr Oncol 20:e420–e41

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Karoui M, Roudot-Thoraval F, Mesli F, et al (2011) Primary colectomy in patients with stage IV colon cancer and unresectable distant metastases improves overall survival: results of a multicentric study. Dis Colon Rectum 54:930–8

    Article  PubMed  Google Scholar 

  8. Yoon YS, Kim CW, Lim SB, et al (2014) Palliative surgery in patients with unresectable colorectal liver metastases: a propensity score matching analysis. J Surg Oncol 109:239–44

    Article  PubMed  Google Scholar 

  9. Gresham G, Renouf DJ, Chan M, et al (2014) Association between palliative resection of the primary tumor and overall survival in a population-based cohort of metastatic colorectal cancer patients. Ann Surg Oncol 21:3917–23

    Article  PubMed  Google Scholar 

  10. Ishihara S, Hayama T, Yamada H, et al (2014) Prognostic impact of primary tumor resection and lymph node dissection in stage IV colorectal cancer with unresectable metastasis: a propensity score analysis in a multicenter retrospective study. Ann Surg Oncol 21:2949–55

    Article  PubMed  Google Scholar 

  11. Venderbosch S, de Wilt JH, Teerenstra S, et al (2011) Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature. Ann Surg Oncol 18: 3252–60

    Article  PubMed  PubMed Central  Google Scholar 

  12. Ferrand F, Malka D, Bourredjem A, et al (2013) Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Fédération francophone de cancérologie digestive 9601. Eur J Cancer 49:90–7

    Article  CAS  PubMed  Google Scholar 

  13. Muratore A, Zorzi D, Bouzari H, et al (2007) Asymptomatic colorectal cancer with un-resectable liver metastases: immediate colorectal resection or up-front systemic chemotherapy? Ann Surg Oncol 14:766–70

    Article  PubMed  Google Scholar 

  14. Karoui M, Soprani A, Charachon A, et al (2010) Primary chemotherapy with or without colonic stent for management of irresectable stage IV colorectal cancer. Eur J Surg Oncol 36:58–64

    Article  CAS  PubMed  Google Scholar 

  15. Douillard JY, Oliner KS, Siena S, et al (2013) Panitumumab-Folfox4 treatment and RAS mutations in colorectal cancer. N Engl J Med 369:1023–34

    Article  CAS  PubMed  Google Scholar 

  16. Van Cutsem E, Lenz HJ, Köhne CH, et al (2015) Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer. J Clin Oncol 33:692–700

    Article  PubMed  Google Scholar 

  17. Bachet JB, Lucidarme O, Taïeb J, et al (2016) Folfirinox as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Results of the FFCD 1102 phase II trial. J Clin Oncol 34(suppl; abstr 3513)

  18. McCahill LE, Yothers G, Sharif S,et al (2012) Primary mFolfox6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10. J Clin Oncol 30:3223–8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Meyerhardt JA, Li L, Sanoff HK (2012) Effectiveness of bevacizumab with first-line combination chemotherapy for Medicare patients with stage IV colorectal cancer. J Clin Oncol 30: 608–15

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Benoist S, Pautrat K, Mitry E, et al (2005) Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg 92:1155–60

    Article  CAS  PubMed  Google Scholar 

  21. Temple LK, Hsieh L, Wong WD, et al (2004) Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol 22:3475–84

    Article  PubMed  Google Scholar 

  22. Panis Y, Maggiori L, Caranhac G, et al (2011) Mortality after colorectal cancer surgery: a French survey of more than 84,000 patients. Ann Surg 254:738–43

    Article  PubMed  Google Scholar 

  23. Stillwell AP, Buettner PG, Siu SK, et al (2011) Predictors of postoperative mortality, morbidity, and long-term survival after palliative resection in patients with colorectal cancer. Dis Colon Rectum 54:535–44

    Article  PubMed  Google Scholar 

  24. http://www.snfge.org/content/cancer-colorectal-metastatique

Download references

Author information

Authors and Affiliations

  1. Service de chirurgie digestive et endocrinienne, centre hospitalier Lyon-Sud, hospices civils de Lyon, 165, chemin du Grand-Revoyet, F-69495, Pierre-Bénite cedex, France

    E. Cotte

  2. Service des maladies de l’appareil digestif, CHU Pontchaillou, 2, rue Henri-Le-Guilloux, F-35033, Rennes cedex 09, France

    A. Lièvre

Authors
  1. E. Cotte
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Lièvre
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to E. Cotte or A. Lièvre.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cotte, E., Lièvre, A. Controverse. Colon Rectum 10, 254–259 (2016). https://doi.org/10.1007/s11725-016-0673-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11725-016-0673-z

Search

Navigation